|
Jun 11
|
Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav®
|
|
Jun 10
|
Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer
|
|
Jun 9
|
Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025
|
|
May 26
|
3 of Wall Street’s Favorite Stocks with Mounting Challenges
|
|
May 23
|
Insiders Pour Millions into These 3 Stocks — Here’s Why They Draw Plaudits Across the Board
|
|
Apr 23
|
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
|
|
Apr 23
|
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak
|
|
Apr 23
|
3 Small-Cap Stocks in the Doghouse
|
|
Apr 22
|
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
|
|
Apr 21
|
Jazz Pharmaceuticals Completes Acquisition of Chimerix
|
|
Apr 21
|
JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?
|
|
Apr 17
|
JAZZ vs. ARGX: Which Stock Is the Better Value Option?
|
|
Apr 17
|
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?
|
|
Apr 17
|
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
|
|
Mar 14
|
JAZZ or ILMN: Which Is the Better Value Stock Right Now?
|
|
Mar 14
|
Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?
|
|
Mar 14
|
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
|
|
Mar 12
|
BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
|
|
Mar 12
|
Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day
|
|
Mar 12
|
Bull of the Day: Jazz Pharmaceuticals (JAZZ)
|